Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Krystal Biotech, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
423 institutional managers report a position in Krystal Biotech, Inc. worth $11.4B between them, filed on form 13F for the quarter ending 2026-06-30. 25 of them hold 80% of it, the largest being FMR LLC at 14.38%.
398 more managers in the register
25 managers hold 80% of the $11.4B institutional base. The other 398 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
KRYS (Krystal Biotech, Inc.) has 0 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via venBio Select Advisor LLC, First Trust Advisors LP, Hood River Capital Management LLC +8 more · 9.40% of KRYS, 9.32% of ARWR
via venBio Select Advisor LLC, William Blair Investment Management, LLC, Norges Bank +7 more · 9.40% of KRYS, 7.63% of MDGL
via venBio Select Advisor LLC, Capital World Investors, Franklin Resources Inc +6 more · 9.40% of KRYS, 7.55% of ASND
via venBio Select Advisor LLC, Franklin Resources Inc, Jupiter Topco LLC +2 more · 9.40% of KRYS, 9.62% of GPCR
via venBio Select Advisor LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC +5 more · 9.40% of KRYS, 5.81% of CELC
via venBio Select Advisor LLC, Norges Bank, Jupiter Topco LLC +6 more · 9.40% of KRYS, 6.38% of UTHR
Managers holding a meaningful stake in KRYS also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.